Skip to main content

A nine-year-old girl has received a devastating diagnosis after her mother noticed her eyes were twinkling.

Nine-year-old Kaycee Bradshaw was diagnosed with a genetic condition called Batten disease when she was just four years old, causing her to suffer from seizures, loss of speech and mobility, muscle spasms and progressive blindness and dementia.

While figures on the number of people in the UK with Batten disease vary, the BDFA (The Batten Disease Family Association) estimate that around 11 to 17 children, young people and adults are diagnosed with some form of the disease. incurable every year.

READ MORE:Reality of life on the abandoned TikTok Primrose Court housing estate

In an effort to combat the disease, in 2017 St Helens-born Kaycee was one of the first children to receive enzyme treatment on her brain at Great Ormond Street Hospital in London, which she continued to do every two weeks since its first treatment.



Kaycee Bradshaw was diagnosed with Batten disease in 2016

Kaycee’s mother, Claire Bradshaw, says that since her daughter started receiving the treatment five and a half years ago, the results have been “absolutely brilliant”.

Claire told ECHO: “In the world of Batten disease, Kaycee shouldn’t be here right now, but she is. She’s still there, that’s how good it is.

“Kaycee was one of the first children in the UK to receive the treatment we had to fight for. We campaigned so hard, we really fought for it and we finally won, which means that now all children diagnosed with this disease will be able to receive treatment immediately.

“It’s not going to save her life, she’s still terminally ill, but it’s going to happen at a much slower rate. We’re extending her life and not her painful times – just her happy times, her laughter and her smiles. . We have a few good years left, and she’s a soldier.”

The Liverpool Echo sends out newsletters on a wide range of topics – including our weekly St Helens Live newsletter which brings you news from across the borough in a way you’ve never had before.

Whether it’s celebrating people, sharing issues or discussing the latest news, our newsletter covers all things St Helens.

There is also our daily newsletter, which now comes out three times a day, as well as other newsletters covering current affairs, politics, court news, Knowsley, Sefton, Wirral and the arts and culture, as well as Liverpool FC and Everton. CF.

It’s free to sign up and it only takes a minute for you to get the biggest stories, delivered straight to your inbox.

How to Sign Up for an Echo Email Update

1) Go to our page dedicated to the newsletter on this link.

2) Put your email in the indicated box

3) Tick Echo St Helens Live and as many boxes as you want, for each newsletter you want.

4) Press Save Changes and that’s it!

The 49-year-old said that before Kaycee’s diagnosis in 2016, she had never heard of Batten disease, but she was not the only one with minimal knowledge of it.



Claire Bradshaw and her daughter Kaycee from St Helens
Claire Bradshaw and her daughter Kaycee from St Helens

She said: ‘When we got the diagnosis we obviously didn’t know much about it, but neither did the nurse we saw.

“The first concerns arose when Kaycee wasn’t speaking properly, she couldn’t hear her words, so we started to wonder ‘is she deaf? “,” is she is that?

“Then she started having eyelid twinkles. I took her to the doctor and she was diagnosed with epilepsy and put some pills on, so we thought we’d live with it and eventually it would work out, but then it kept going down.

“She started to adapt and she ended up with broken teeth and broken bones because when she fell to the ground she didn’t stop like any other child – her mobility was gone.

“She had gone from walking and not having diapers, to suddenly not walking – only with our help – and back in diapers 12 months later.”

The mother-of-six said she was initially told her daughter could only expect to live to be eight or 10 years old. However, more recently, Claire was told to “start looking for a caregiver” as Kaycee will “most likely outlive her”.



Kaycee Bradshaw was diagnosed with Batten disease in 2016
Kaycee Bradshaw was diagnosed with Batten disease in 2016

With the treatment a success over the past five years, Kaycee has now been selected as one of eight children who will take part in a new trial that aims to save the sight in one of her eyes.

The trial was only made possible after an extensive fundraising campaign by families of children affected by the disease and the Batten Disease Family Association (BDFA). In total they have raised over £200,000, in the hope the trial can change the lives of others.

The 18-month treatment trial, which is already a success in animal studies, involves injecting a drug called Brineura, which is already used to slow the disease, directly into the eye.

Doctors at Great Ormond Street Hospital believe the drug may save the sight of children with CLN2 type Batten disease.

Claire said if it could save just one of her daughter’s eyes, it would “make such a big difference to her quality of life”.

She said the trial, which began in August, gave them “hope” for Kaycee and other children with Batten disease.

Claire said: “Kaycee was the third in the world to start this treatment and hopefully this will mean she can keep sight in her right eye.

“Her sight is her life. All her smiles and her life come from sight, she can watch the grandchildren grow up and see the birds.

“Take that away, there’s nothing left.

“In 18 months his left eye will be gone, but his left will be too if we don’t try this – it’s just a waiting game now.”



Kaycee Bradshaw receives specialist 'enzyme infusion' treatment at Great Ormond Street Hospital in London every fortnight
Kaycee Bradshaw receives specialist ‘enzyme infusion’ treatment at Great Ormond Street Hospital in London every fortnight

The drug injected aims to restore enzymes in the nervous system that are not working or recycling waste products properly.

The breakthrough treatment works by restoring a “missing” enzyme that the nerves at the back of the eyes need to function.

At the end of the trial which will see Kaycee, along with four boys and three other girls, receive nine doses of the drug once every eight weeks, medical professionals will compare the difference in vision between the children’s eyes to see if the treatment has proven itself. effective.

Receive newsletters with the latest news, sport and updates from ECHO Liverpool by signing up here